Home | Company | Contact Us
Financials
Products
Financials
Code of Conduct
Corporate Social
Contribution
People
Financial Reports
Shareholding
Five Years at a glance




Financial Reports

Previous Year
Year 2012 - 13Year 2011 - 12Year 2010 - 11
Half yearly
Director's Report
Profit and loss Account
Balance Sheet
Statement of changes in equity
Cash flow Statement

Quarterly
March 2013
Director's Report
Profit and loss Account
Balance Sheet
Statement of changes in equity
Cash flow Statement

September 2012
Director's Report
Profit and loss Account
Balance Sheet
Statement of changes in equity
Cash flow Statement
Annual
Director's Report
Profit and loss Account
Balance Sheet
Statement of changes in equity
Cash flow Statement

Half yearly
Director's Report
Profit and loss Account
Balance Sheet
Statement of changes in equity
Cash flow Statement

Quarterly
March 2012
Director's Report
Profit and loss Account
Balance Sheet
Statement of changes in equity
Cash flow Statement

September 2011
Director's Report
Profit and loss Account
Balance Sheet
Statement of changes in equity
Cash flow Statement
Annual

Profit and loss Account
Balance Sheet
Statement of changes in equity
Cash flow Statement

Half yearly
Director's Report
Profit and loss Account
Balance Sheet
Statement of changes in equity
Cash flow Statement

Quarterly
March 2011
Director's Report
Profit and loss Account
Balance Sheet
Statement of changes in equity
Cash flow Statement

September 2010
Director's Report
Profit and loss Account
Balance Sheet
Statement of changes in equity
Cash flow Statement


Back to top

Shareholding



Capital
Authorized & paid up Capital.Rs.100 Million

Shareholding
Otsuka Pharmaceutical Co., Ltd (Japan) 45%
P.T.Otsuka Indonesia (Indonesia) 10%
Feroz Family Karachi 30%
General Public (Including National Investment Trust) 15%


Back to top

Five Years at a Glance



   A Sign of Japanese Commitment to Better Health
Copyright 2010. All Rights ReservedDisclaimer